Literature DB >> 17465078

Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17465078

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  12 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

2.  Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host.

Authors:  Matthew J Memoli; Rachel J Hrabal; Arash Hassantoufighi; Brett W Jagger; Zong-Mei Sheng; Maryna C Eichelberger; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2010-05-01       Impact factor: 5.226

3.  Competitive fitness of influenza B viruses with neuraminidase inhibitor-resistant substitutions in a coinfection model of the human airway epithelium.

Authors:  Andrew J Burnham; Jianling Armstrong; Anice C Lowen; Robert G Webster; Elena A Govorkova
Journal:  J Virol       Date:  2015-02-11       Impact factor: 5.103

Review 4.  Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Authors:  Regina Dutkowski
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

5.  Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses.

Authors:  Aaron J Oakley; Susan Barrett; Thomas S Peat; Janet Newman; Victor A Streltsov; Lynne Waddington; Takehiko Saito; Masato Tashiro; Jennifer L McKimm-Breschkin
Journal:  J Med Chem       Date:  2010-09-09       Impact factor: 7.446

6.  Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal:  Clin Infect Dis       Date:  2009-04-15       Impact factor: 9.079

7.  Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan.

Authors:  Makoto Ujike; Kozue Shimabukuro; Kiku Mochizuki; Masatsugu Obuchi; Tsutomu Kageyama; Masayuki Shirakura; Noriko Kishida; Kazuyo Yamashita; Hiroshi Horikawa; Yumiko Kato; Nobuyuki Fujita; Masato Tashiro; Takato Odagiri
Journal:  Emerg Infect Dis       Date:  2010-06       Impact factor: 6.883

8.  Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.

Authors:  Adam Meijer; Angie Lackenby; Olav Hungnes; Bruno Lina; Sylvie van-der-Werf; Brunhilde Schweiger; Matthias Opp; John Paget; Jan van-de-Kassteele; Alan Hay; Maria Zambon
Journal:  Emerg Infect Dis       Date:  2009-04       Impact factor: 6.883

9.  Impact of emerging antiviral drug resistance on influenza containment and spread: influence of subclinical infection and strategic use of a stockpile containing one or two drugs.

Authors:  James M McCaw; James G Wood; Christopher T McCaw; Jodie McVernon
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

Review 10.  Complications of viral influenza.

Authors:  Michael B Rothberg; Sarah D Haessler; Richard B Brown
Journal:  Am J Med       Date:  2008-04       Impact factor: 4.965
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.